Back to Authors

Berry, Gerald J.

https://orcid.org/0000-0002-6176-2629

Mayo Clinic

Stanford Medicine

Citations 12

Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis
Zhang, Hui , Watanabe, Ryu , Berry, Gerald J. , Liao, Yaping Joyce , Warrington, Kenneth J. , Goronzy, Jörg J. , Weyand, Cornelia M. , Vaglio, Augusto , Warrington, Kenneth J , Goronzy, Jorg , Berry, Gerald J

Proceedings of the National Academy of Sciences | January 23, 2017 | Volume: 114 | Issue: 6 | Pages: No page available

10.1073/pnas.1616848114 Get It

Significance Antigen recognition by the immune system triggers rapid, specific, and protective responses, which are counterbalanced by inhibitory checkpoints to minimize potentially harmful immunity. The programmed death-1/ programmed death ligand-1 (PD-1/PD-L1) checkpoint is overreactive in cancer patients, curbing antitumor immunity. Whether a failing PD-1/PD-L1 checkpoint contributes to spontaneous autoimmune disease in humans is unknown. Here, we found that in patients with the autoimmune vasculitis giant cell arteritis, antigen-presenting cells provide insufficient negative signaling; unleashing highly activated T cells to infiltrate and damage the walls of large arteries. Thus, immunoinhibitory signals protect large arteries against inflammatory attack and checkpoint activation may be a suitable strategy to treat autoimmune vasculitis.
Thoracic Lymphangiomas, Lymphangiectasis, Lymphangiomatosis, and Lymphatic Dysplasia Syndrome
Faul, John L. , Colby, Thomas V. , Ruoss, Stephen J. , WALTER, MATTHEW B., Raffin, Thomas A., Berry, Gerald J. , Rosen, Glenn D.

American Journal of Respiratory and Critical Care Medicine | April 4, 2013 | Volume: 161 | Issue: 3 | Pages: 1037-1046

10.1164/ajrccm.161.3.9904056 Get It